Woodline Partners LP Pliant Therapeutics, Inc. Transaction History

Woodline Partners LP

$19.5 Billion
Q3 2025

A detailed history of Woodline Partners LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 4,504,817 shares of PLRX stock, worth $7.79 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,504,817

Previous 2,348,526 91.81%

Holding current value

$7.79 Million

Previous $2.72 Million 144.75%

% of portfolio

0.03%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.18 - $1.86 $2.54 Million - $4.01 Million	2,156,291 Added 91.81%	4,504,817 $6.67 Million
Q2 2025 Aug 14, 2025	SELL	$1.16 - $1.69 $192,047 - $279,793	-165,558 Reduced 6.59%	2,348,526 $2.72 Million
Q1 2025 May 15, 2025	BUY	$1.35 - $13.53 $3.22 Million - $32.3 Million	2,386,789 Added 1875.01%	2,514,084 $3.39 Million
Q4 2024 Feb 14, 2025	BUY	$10.55 - $15.7 $164,949 - $245,469	15,635 Added 14.0%	127,295 $1.68 Million
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $84,549 - $115,330	8,037 Added 7.76%	111,660 $1.25 Million

Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $36,818 - $54,322	3,480 Added 3.48%	103,623 $1.11 Million
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $338,610 - $469,121	-23,947 Reduced 19.3%	100,143 $1.49 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $4.01 Million - $5.98 Million	-312,162 Reduced 71.56%	124,090 $2.25 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $2.61 Million - $3.6 Million	178,754 Added 69.42%	436,252 $7.56 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $4.67 Million - $7.87 Million	257,498 New	257,498 $4.67 Million
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.26 $2.21 Million - $3.29 Million	-179,993 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $1.79 Million - $3.14 Million	108,330 Added 151.17%	179,993 $3.04 Million
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $2.01 Million - $2.7 Million	71,663 New	71,663 $2.09 Million
Q4 2020 Feb 16, 2021	SELL	$19.89 - $32.99 $3.02 Million - $5.01 Million	-152,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$21.54 - $29.53 $3.27 Million - $4.49 Million	152,000 New	152,000 $3.44 Million

Others Institutions Holding PLRX

# of Institutions

113

Shares Held

58.9M

Call Options Held

209K

Put Options Held

102K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $84.2M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Pliant Therapeutics, Inc. Transaction History